Voices Amplified: Advocacy, Pricing, and Policy Progress
Senate testimony spotlights MedTech, while regulatory updates continue to shape the future.
AdvaMed recaps a pivotal week that included Scott Whitaker’s Senate Finance Committee testimony—members are urged to amplify engagement across platforms. Policy updates include new activity on the Kennedy v. Braidwood case, further engagement on Executive Orders related to procurement reform, and a new EO on drug pricing that aims to align U.S. prices with international benchmarks. AdvaMed continues to respond to RFIs from OMB, HHS, DOJ, and CMS focused on regulatory streamlining and innovation. Members can access submissions, view testimony, and participate in shaping future advocacy.
Watch Scott’s testimony, review the latest RFIs, and join our call for smart regulation.